Scinovex
review Open AccessTop 1% cited

The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

Journal of Neurochemistry · 2009 · Vol. 110(4) · pp. 1129–1134
John Hardy

Abstract

The amyloid hypothesis has been the basis for most work on the pathogenesis of Alzheimer's disease. Recent clinical trials based on this hypothesis have been inconclusive. In this article I review the current status of the hypothesis and suggest that a major scientific need is to understand the normal function of amyloid-beta precursor protein (APP) and think how this may relate to the cell death in the disease process.

Alzheimer's disease research and treatmentsComputational Drug Discovery MethodsPrion Diseases and Protein MisfoldingBiochemistry of Alzheimer's diseaseDiseaseAlzheimer's diseaseAmyloid (mycology)NeurosciencePathogenesisAmyloid precursor proteinPsychologyMedicinePathology

MeSH terms

Alzheimer DiseaseBrainCerebral ArteriesClinical Trials as TopicHumansNerve DegenerationAmyloid beta-PeptidesAmyloid beta-Protein PrecursorDisease ProgressionAlzheimer Vaccines
Citations
802
FWCI
33.57
field-weighted impact
References
75
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal · Scinovex